ELZONRIS 1000 MCG in 1 ML Injection
- RxCUI
- 2109064
- RxNorm name
- ELZONRIS 1000 MCG in 1 ML Injection
- Display name
- ELZONRIS 1000 MCG in 1 ML Injection
- Full name
- ELZONRIS 1000 MCG in 1 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761116 | Elzonris | tagraxofusp-erzs | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Elzonris | TAGRAXOFUSP | Stemline Therapeutics, Inc. | 80eb1080-fe20-4af0-b2a5-a67999923fa8 | 2024-12-09 | Boxed warning, Warnings, Adverse reactions | 2109064 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 80eb1080-fe20-4af0-b2a5-a67999923fa8 | ELZONRIS 1000 MCG in 1 ML Injection | PSN | 11 | These highlights do not include all the information needed to use ELZONRIS ® safely and effectively. See full prescribing information for ELZONRIS. ELZONRIS (tagraxofusp-erzs) injection, for intravenous use Initial U.S. Approval: 2018 | 20241209 |
| 80eb1080-fe20-4af0-b2a5-a67999923fa8 | 1 ML tagraxofusp-erzs 1 MG/ML Injection [Elzonris] | SBD | 11 | These highlights do not include all the information needed to use ELZONRIS ® safely and effectively. See full prescribing information for ELZONRIS. ELZONRIS (tagraxofusp-erzs) injection, for intravenous use Initial U.S. Approval: 2018 | 20241209 |
| 80eb1080-fe20-4af0-b2a5-a67999923fa8 | 1 ML Elzonris 1 MG/ML Injection | SY | 11 | These highlights do not include all the information needed to use ELZONRIS ® safely and effectively. See full prescribing information for ELZONRIS. ELZONRIS (tagraxofusp-erzs) injection, for intravenous use Initial U.S. Approval: 2018 | 20241209 |